Skip To Main Content
K.N. Roy Chengappa on Muck Rack

K.N. Roy Chengappa

As seen in: Color Research & Application, Wiley, Biological Psychiatry
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to K.N. Roy Chengappa’s profile

Articles by K.N. Roy Chengappa

Novel Ideas for Drug Discovery in the Treatment of People With Schizophrenia

|
By K.N. Roy Chengappa
| Biological Psychiatry Verified
Get full text access Log in, subscribe or purchase for full access. References 1. Paul, S.M. ∙ Yohn, S.E. ∙ Brannan, S.K. ... Muscarinic receptor activators as novel treatments for schizophrenia Biol Psychiatry. 2024; 96:627-637 2. Bolbecker, A.R. ∙ Shekhar, A. Muscarinic agonists and antagonists in schizophrenia Springer, Berlin, Germany, Fryer, A. ∙ Christopoulos, A. ∙ Nathanson, N. in: Muscarinic Receptors. Handbook of Experimental Pharmacology. vol. 208. 2012; 167-190 3. Shekhar, A.
Open in Who Shared Issue with article?

Group teletherapy for first‐episode psychosis: Piloting its integration with coordinated specialty care during the COVID‐19 pandemic

|
By Helen Wood, Jessica M. Gannon, K.N. Roy Chengappa, Deepak K. Sarpal
| Wiley Online Library Verified
Abstract Digital health has emerged in recent years as a tool to optimize care delivery and promote treatment adherence among individuals with first‐episode psychosis (FEP). Recent mandates for social distancing and sheltering in place due to the COVID‐19 pandemic have catapulted efforts to provide ongoing coordinated specialty care (CSC) on virtual platforms.
Open in Who Shared Issue with article?
Show More